Terns Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets. Based in San Mateo, California and Shanghai, Terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in China and globally.
Terns Pharmaceuticals has raised $87.0M across 1 funding round on record, the most recent a Series C of $87.0M announced in Jan 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Terns Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jan 2021.
Terns Pharmaceuticals Funding Rounds
Terns Pharmaceuticals Founders and Leadership Team
Contact details for the Terns Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Terns Pharmaceuticals Funding Compared to Other Biotechnology Startups
Terns Pharmaceuticals' latest round of $87.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Terns Pharmaceuticals in Biotechnology and San Mateo
Companies Similar to Terns Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Terns Pharmaceuticals Funding FAQs
What does Terns Pharmaceuticals do?
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets. Based in San Mateo, California and Shanghai, Terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in China and globally.
How much funding has Terns Pharmaceuticals raised?
Terns Pharmaceuticals has raised $87.0M across 1 round on record. The most recent is a Series C of $87.0M announced in Jan 2021.
When did Terns Pharmaceuticals last raise funding?
Terns Pharmaceuticals' most recent funding round on record is a Series C of $87.0M, announced in Jan 2021.
Who is the CEO of Terns Pharmaceuticals?
Senthil Sundaram is listed as CEO at Terns Pharmaceuticals.
Where is Terns Pharmaceuticals headquartered?
Terns Pharmaceuticals is based in San Mateo, California, United States.
How many employees does Terns Pharmaceuticals have?
Terns Pharmaceuticals is in the 11-50 employee band.
How does Terns Pharmaceuticals' funding compare to other Biotechnology startups?
Terns Pharmaceuticals' latest round of $87.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Terns Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Terns Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.